RIO DE JANEIRO, BRAZIL - Preliminary results from a study on Chloroquine by Fiocruz and the Tropical Medicine Foundation showed that mortality among the group of Covid-19 patients tested, in critical condition, was 13 percent.
Of the 81 inpatients who were given the drug, 11 died. The mortality rate for patients in the same conditions who were not given the drug is 18 percent, according to international studies, including China. The closeness of the two indices does not allow asserting, for the time being, that Chloroquine could be instrumental in the treatment of patients infected with the novel coronavirus.
"Optimists . . .
To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here